KelSie Biotech specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process
KelSie Biotech specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process. The company offers a range of services including formulation development, testing, licensing, trial design, and manufacturing.
KelSie Biotech specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process
KelSie Biotech specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process. The company offers a range of services including formulation development, testing, licensing, trial design, and manufacturing.